Bromodomain and exoterminal motif (BET) inhibitors are a class of small-molecule drugs that reversibly bind to the bromodomain and exoterminal motif BET proteins BRD2, BRD3, BRD4, and the bromodomains of BRDT. These BET inhibitors are drugs that prevent protein-protein interactions between BET proteins and acetylated histones and transcription factors. Deregulated bromodomains of BET proteins are frequently found in cancer and display aberrant chromatin remodeling and gene expression.















![l-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-lHpyrazolo [3,4-d]pyrimidin-l-yl]-l-piperidinyl]-2-propyn-l-one](https://e1752fbe.rocketcdn.me/wp-content/uploads/AP14272-CAS-936563-91-6-1-e1686054563587.png)





![N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine](https://e1752fbe.rocketcdn.me/wp-content/uploads/AP14270-CAS-231278-20-9-1-e1686064939791.png)


